CORZ Stock Down -29% after 5-Day Loss Streak
Core Scientific (CORZ) stock hit day 5 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -29% return. The company has lost about $1.2 Bil in value over the last 5 days, with its current market capitalization at about $4.2 Bil. The stock remains 11.0% below its value at the end of 2024. This compares with year-to-date returns of 6.4% for the S&P 500.
Comparing CORZ Stock Returns With The S&P 500
The following table summarizes the return for CORZ stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | CORZ | S&P 500 |
|---|---|---|
| 1D | -5.1% | -0.3% |
| 5D (Current Streak) | -28.8% | 0.5% |
| 1M (21D) | -1.6% | 4.2% |
| 3M (63D) | 92.2% | 25.6% |
| YTD 2025 | -11.0% | 6.4% |
| 2024 | 23.3% | |
| 2023 | 24.2% | |
| 2022 | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 42 S&P constituents with 3 days or more of consecutive gains and 50 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 23 | 24 |
| 4D | 15 | 15 |
| 5D | 0 | 4 |
| 6D | 2 | 4 |
| 7D or more | 2 | 3 |
| Total >=3 D | 42 | 50 |
- Freeport-McMoRan Earnings: The Good, the Bad, and the Grasberg
- Can Newmont Keep Riding The Gold Rally Into 2027?
- Intel, Lam, KLA: Will Musk’s $120B Terafab Boost These Stocks?
- Get Paid 10% To Buy NVDA At A 30% Discount, Here’s How
- How CVS Health’s Transformation Is Facing A Hard Valuation Floor
- Is UBER Stock Undervalued At $80?
Key Financials for Core Scientific (CORZ)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $502.4 Mil | $510.7 Mil |
| Operating Income | $15.3 Mil | $-12.2 Mil |
| Net Income | $-246.5 Mil | $-1.3 Bil |
Last 2 Fiscal Quarters:
| Metric | 2024 FQ4 | 2025 FQ1 |
|---|---|---|
| Revenues | $94.9 Mil | $79.5 Mil |
| Operating Income | $-39.6 Mil | $-42.6 Mil |
| Net Income | $-265.5 Mil | $580.7 Mil |
The losing streak CORZ stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.